Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 130 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 7/1/1990


1.		Phase II/III Combination Chemotherapy with FAME (5-FU/ADR/MeCCNU) vs FAP (5-FU/ADR/CACP) vs FAME Alternating with TZT vs 5-FU Alone for Advanced Gastric Carcinoma (Summary Last Modified 07/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				18 and over				NCI				NCCTG-834151 MAYO-834151, NCCTG-83-41-51


2.		Phase II/III Chemotherapy with Intraperitoneal CDDP in Patients with Ovarian Carcinoma Limited to the Peritoneal Cavity

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								UCLA-81021523 NCI-V83-0303


3.		Phase II/III Randomized Comparison of PF (CACP/5-FU) vs MVPF (MITO/VCR/CACP/5-FU) in Advanced Large Bowel Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified				NCI				EST-1285

Last Modified: 7/5/2007


4.		Phase III Randomized Comparison of Combination Chemotherapy with CBDCA/CTX vs CACP/CTX in Patients with Stage III/IV Ovarian Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase I				Treatment				Completed				18 and over				NCI				SWOG-8412


5.		Phase III Preoperative Radiotherapy plus MTX/BLEO/CACP vs Conventional Therapy for Stage III-IV and Recurrent Intraoral Squamous Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				85 and under								NCI-D78-005-053 CCOG-784


6.		Phase III Preoperative Chemotherapy with CACP/MTX/BLEO/VCR plus Postoperative Radiotherapy for Untreated Stage III-IV Head & Neck Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NCI-D78-035-102


7.		Phase III Combination Chemotherapy with VBL/BLEO and Sequential Chemotherapy with CACP for Advanced Testicular and Extragonadal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MDAR-175


8.		Phase III VAM (VCR/ADR/MTX) vs ADR for Thyroid Carcinoma Not Amenable to Other Therapy Modalities

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NCI-D79-026-161 RPMI-997906


9.		Phase III Chemotherapy with ADR/CTX/CACP Followed by Orchiectomy or Hormone Therapy with DES for Chemotherapy Failures with Metastatic Prostatic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 70								NCI-78-C-56 NCI-NMOB-814

Last Modified: 4/1/1997


10.		Phase III Pre- and Postoperative Combination Chemotherapy Including High-Dose MTX in Children with Previously Untreated Nonmetastatic Osteogenic Sarcoma of an Extremity (Summary Last Modified 04/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				2 to 21				NCI				CCG-782

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute